See also this year's filing and all EDGAR filings for this company.
PDF Report 0000078003_2026_Pfizer_INC.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 5.753615368012087, 'aggregate_val': 62579000000, 'exp_sum': 9266000000, 'exp_to_value': {'remainder_Revenues': 9266000000}} |
Graph
Absolute values for 0000078003, Pfizer INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 42,898,000,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 124,995,000,000 |
| 2 | PropertyPlantAndEquipmentNet | 19,317,000,000 |
| 3 | remainder_Assets | 20,950,000,000 |
| 4 | LiabilitiesCurrent | 36,984,000,000 |
| 5 | LiabilitiesNoncurrent | 76,366,000,000 |
| 6 | remainder_Liabilities | 8,035,000,000 |
| 7 | CostOfGoodsAndServicesSold | 15,725,019,078 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,414,774,935 |
| 9 | ResearchAndDevelopmentExpense | 12,180,606,666 |
| 10 | remainder_Expenses | 5,858,079,501 |
| 11 | remainder_Revenues | 62,527,124,360 |
| 12 | remainder_NetIncome | -6,166,815,784 |
| 13 | remainder_ComprehensiveNetIncome | -117,182,484 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 208,160,000,000 |
| 1 | Liabilities | 121,385,000,000 |
| 2 | Expenses | 47,178,480,180 |
| 3 | Revenues | 62,527,124,360 |
| 4 | StockholdersEquity | 86,775,000,000 |
| 5 | NetIncome | 9,181,828,396 |
| 6 | ComprehensiveNetIncome | 9,123,237,154 |
| 7 | BaseVar | 222,767,301,404 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.20 |
| 9 | EconomicCapitalRatio | 2.46 |
Edgar->Model Mapping
Feature Distribution
Change over Time
